Browse the latest research summaries in the field of genetics for spinal cord injury patients and caregivers.
Showing 431-440 of 1,773 results
eNeuro, 2024 • February 1, 2024
This study investigates the potential of cypin inhibition as a therapeutic approach for SCI-induced neuropathic pain using the small molecule inhibitor B9 in a mouse model. The key finding is that B9 ...
KEY FINDING: B9 alleviates mechanical pain after SCI. Intrathecal administration of B9, starting at 1 day postinjury (dpi) until 7 dpi, attenuates mechanical pain in hindlimbs at 3 weeks pi.
Neurochem Int, 2024 • March 1, 2024
Mild mitochondrial uncoupling is a novel therapeutic approach for TBI and accumulating evidence suggests that it can restore neurobehavioral outcomes. We propose in this article that mitochondrial unc...
KEY FINDING: Deficits in mitochondrial function and metabolism are considered driving forces in progressive energy crisis developed after TBI.
Burns & Trauma, 2024 • January 1, 2024
Burn injuries have widespread sequelae that affect many body systems including the CNS. In this review we have explored the different ways that a burn affects the CNS. There is now significant and acc...
KEY FINDING: Burn injuries can lead to CNS-related sequelae, including neural apoptosis, hyperalgesia, and changes in metabolism and cognitive function.
Front. Cell Dev. Biol., 2024 • January 19, 2024
This review summarizes the pathogenic mechanisms of IDD and the role of the p38 MAPK signaling pathway in its development. P38 MAPK is actively expressed during IDD and influences its progression by r...
KEY FINDING: The p38 MAPK signaling pathway is involved in multiple processes of IDD, including inflammation, ECM degradation, apoptosis, senescence, proliferation, oxidative stress, and autophagy.
The Journal of Neuroscience, 2024 • February 7, 2024
This study investigates the role of TLR4 signaling in chronic SCI using TLR4 null and wild-type mice, focusing on molecular, cellular, and ECM changes at 1 day, 7 days, and 8 weeks post-injury. The re...
KEY FINDING: TLR4 deletion reduces neuronal and myelin loss, decreasing secondary damage at 8 weeks post-SCI.
Analytical and Bioanalytical Chemistry, 2024 • February 7, 2024
This study combines LIMS and IHC to analyze lipid changes in a mouse model of spinal cord injury, identifying distinct lipid fingerprints in different lesion areas. The research reveals significant al...
KEY FINDING: The study identified distinct lipid fingerprints in the lesion core, peri-lesion (the lesion front rich in infiltrating cells), and uninvolved tissue, demonstrating a clear difference in lipid signature between the lesion front and the epicentre.
CNS Neurosci Ther, 2024 • January 1, 2024
Interleukin (IL)-38 is a newly discovered cytokine of the IL-1 family, which binds various receptors (i.e., IL-36R, IL-1 receptor accessory protein-like 1, and IL-1R1) in the central nervous system (C...
KEY FINDING: IL-38 alleviates neuromyelitis optica disorder (NMOD) by inhibiting Th17 expression.
Int. J. Mol. Sci., 2024 • February 1, 2024
This study examines the time-dependent changes in the spine, dorsal root ganglion (DRG), and spinal cord in a rat model of discogenic pain caused by annulus fibrosus (AF) injury. The research demonstr...
KEY FINDING: AF injury induces acute inflammation in the spine, DRG, and spinal cord, followed by chronic glial responses in the DRG and spinal cord.
eNeuro, 2024 • February 1, 2024
The study demonstrates that small extracellular vesicles (EVs) released from bone marrow mesenchymal stem cells (BMSCs) overexpressing miR-211-5p can ameliorate spinal cord injuries (SCI) in rats. The...
KEY FINDING: MiR-211-5p targets COX2 mRNA and regulates its protein expression in BMSCs, suggesting a role in controlling inflammation.
Stem Cell Reports, 2024 • March 12, 2024
This study demonstrates that ex vivo gene therapy with CPTX-expressing hiPSC-NS/PCs enhances synapse formation and functional recovery in a rat model of SCI. The findings indicate that CPTX promotes t...
KEY FINDING: CPTX expression in transplanted hiPSC-NS/PCs significantly increased excitatory synapse formation at the transplantation site.